Preparation, characterization and in vivo studies of proliposomes containing cyclosporine A

Journal of Nanoscience and Nanotechnology

Volumn 6, Issue 9-10, 2006, Pages 2967-2973

  Shah, Neha M ^a   Parikh, Jolly ^a   Namdeo, Alok ^b   Subramanian, N ^b   Bhowmick, Subhash ^a  

^a SARDAR PATEL UNIVERSITY   (India)

^b Sun Pharma Advanced Research Centre   (India)

Author keywords

Cyclosporine A; Liposomal Cyclosporine; Oral Bioavailability; Proliposomes

Indexed keywords

BIOAVAILABILITY; CYCLOSPORINE A; ORAL BIOAVAILABILITY; PROLIPOSOMES;

CONTROLLED DRUG DELIVERY; HYDRATION; METHANOL; MORPHOLOGY; PARTICLE SIZE ANALYSIS; SCANNING ELECTRON MICROSCOPY; SPRAYING; SUGARS; TRANSMISSION ELECTRON MICROSCOPY;

DRUG PRODUCTS;

CYCLOSPORIN; DRUG CARRIER; LIPOSOME; NANOMATERIAL;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; DIFFUSION; MALE; METABOLIC CLEARANCE RATE; PARTICLE SIZE; RAT; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; CYCLOSPORINE; DIFFUSION; DRUG CARRIERS; LIPOSOMES; MALE; METABOLIC CLEARANCE RATE; NANOSTRUCTURES; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33750069158     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2006.403     Document Type: Conference Paper

References (21)

1. D. D. Verma and A. Fahr, J. Control. Rel. 97, 55 (2004).
2. S. P. Vyas and R. K. Khar, Targeted and Controlled Drug Delivery, Novel Carrier Systems, 1st ed., CBS Publishers, New Delhi (2002), pp. 173-247.
3. M. A. Al-Meshal, S. H. Khidr, M. A. Bayomi, and A. A. Al-Angary, Int. J. Pharmaceutics 168, 163 (1998).
4. J. J. Curtis and D. A. Laskow, Transplant. Proc. 20, 540 (1988).
5. M. K. Lee, L. Choi, M. H. Kim, and C. K. Kim, Int. J. Pharmaceutics 191, 87 (1999).
6. W. K. Lee, J. Y. Park, H. E. Yang, H. Suh, S. U. Kim, D. S. Chung, K. Choi, C. W. Yang, and J. S. Park. J. Control. Rel. 84, 115 (2002).
7. Y. Ran, L. Zhao, Q. Xu, and S. H. Yalkowsky, AAPS Pharm. Sci. Tech. 2(1): article 2 (2001).
8. S. Venkatraman, W. M. Awni, K. Jordan, and Y. E. Rahman, J. Pharm. Sci. 79, 216 (1991).
9. D. M. Lidgate, P. L. Felgner, J. S. Fleitman, J. Whatley, and R. C. Fu, Pharm. Res. 5, 759 (1988).
10. A. A. Al-Angary, M. A. Bayomi, S. H. Khidr, M. A. Al-Meshal, and M. Al-Dardiri, Int. J. Pharmaceutics 114, 221 (1995).
11. D. Masin, E. Choice, M. B. Bally, M. Meloche, and T. D. Madden, Transplantation 60, 1006 (1995).
12. M. Fukunaga, M. M. Miller, and L. J. Deftos, Horm. Metab. Res. 23, 166 (1991).
13. C. Ouyang, E. Choice, J. Holland, M. Meloche, and T. D. Madden, Transplantation 60, 999 (1995).
14. J. Guo, Q. Ping, and Y. Chen, Int. J. Pharmaceutics 216, 17 (2001).
15. R. M. Fielding, Clin. Pharmacokint 21, 155 (1991).
16. N. I. Payne, P. Timmins, C. V. Ambrose, M. D. Ward, and F. Ridgway, J. Pharm. Sci. 75, 325 (1986a).
17. N. I. Payne, I. Browning, and C. A. Hynes, J. Pharm. Sci. 75, 330 (1986b).
18. A. I. Welsch and D. G. Rhodes, Pharm. Res. 18, 656 (2001).
19. K. H. Song, S. J. Chung, and C. K. Shim, J. Control. Rel. 84, 7 (2004).
20. X. Wang, J. Daia, Z. Chena, T. Zhang, G. Xiab, T. Nagaic, and Q. Zhang, J. Control. Rel. 97, 421 (2004).
21. J. Reymond, H. Sucker, and J. Vonderscher, Pharm. Res. 5, 677 (1988).